CloudMD: Canaccord Raises Price Target To $3.75

Wednesday morning, it was announced that CloudMD Software & Services (TSXV: DOC) is acquiring VisionPros, a vertically integrated eyecare platform. The deal will cost CloudMD C$60 million along with a potential one-time C$40 million earnout. The C$60 million comes in one C$30 million cash payment and one C$30 million payment in common shares of the company. Following this, they also announced a C$45 million bought deal, which was upsized yesterday morning to C$55 million.

CloudMD currently has five analysts covering the company with a weighted 12-month price target of C$3.91. This is slightly up from the average in January, which was C$3.33. One analyst has a strong buy rating, while the other four analysts have buy ratings.

Canaccord’s Doug Taylor raised CloudMD’s 12-month price target to C$3.75 from C$3.25 while reiterating their speculative buy rating on the name. He writes, “Today’s announcement represents the single largest acquisition DOC has undertaken and brings the company’s annualized revenue run rate to over $85M.” He also believes that this deal could bring potential cross-selling opportunities for patients.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

In the news release, CloudMD noted that VisionPro had generated over C$22m in revenue with a >10% EBITDA margin during 2020. Taylor writes, “The deal is financially accretive, with upfront consideration representing 2.7x trailing revenue (4.5x including earnouts) vs. DOC 8.7x 2021E EV/Sales.” Taylor believes that gross margin is in-line with CloudMD’s of 30% and says that if the earnout were trigged by VisionPro growing 50% annually across 2021 and 2022, it would make Canaccord upgrade their forecast.

Alongside the potential cross-selling, Taylor believes the potential exists for synergies with CloudMD’s Rx Infinity digital pharmacy acquisition. Below you can see the key estimates that Canaccord has made for 2021 and 2022 for the firm.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

One Response

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

CloudMD Telehealth Platform Increases Onboarding

CloudMD Software & Services (CSE: DOC) announced this morning that they are currently in the...

Monday, March 9, 2020, 07:52:56 AM

BMO Lifts Endeavour Silver’s Price Target Following Better Than Expected Q1 Results

On April 11th, Endeavour Silver Corp. (TSX: EDR) announced its first quarter of 2021 production...

Thursday, April 14, 2022, 11:24:00 AM

Lundin Mining: BMO Lowers Target After Weaker Than Expected Guidance

On November 22nd, Lundin Mining Corporation (TSX: LUN) provided production guidance all the way out...

Wednesday, November 24, 2021, 04:18:00 PM

Cineplex: BMO Reiterates Targets Despite Earnings Missing Consensus

Cineplex Inc. (TSX: CGX) reported its second quarter financial results last week. The company announced...

Monday, August 15, 2022, 12:24:00 PM

BMO Cuts Sandstorm Gold’s Price Target After Underwriting Financing

On October 4, Sandstorm Gold (TSX: SSL) announced the closing of their bought deal financing....

Thursday, October 6, 2022, 03:55:00 PM